142 related articles for article (PubMed ID: 25986246)
1. 6-OHDA-Induced Changes in Parkinson's Disease-Related Gene Expression are not Affected by the Overexpression of PGAM5 in In Vitro Differentiated Embryonic Mesencephalic Cells.
Stępkowski TM; Wasyk I; Grzelak A; Kruszewski M
Cell Mol Neurobiol; 2015 Nov; 35(8):1137-47. PubMed ID: 25986246
[TBL] [Abstract][Full Text] [Related]
2. Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons.
Misiak M; Beyer C; Arnold S
Biochim Biophys Acta; 2010; 1797(6-7):1178-88. PubMed ID: 20416276
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro.
Kurowska Z; Brundin P; Schwab ME; Li JY
Neuroscience; 2014 Jan; 256():456-66. PubMed ID: 24157929
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
5. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice.
Iwata S; Nomoto M; Morioka H; Miyata A
Synapse; 2004 Mar; 51(4):279-86. PubMed ID: 14696015
[TBL] [Abstract][Full Text] [Related]
7. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X
Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of the beneficial effect of melatonin in experimental Parkinson's disease.
Yildirim FB; Ozsoy O; Tanriover G; Kaya Y; Ogut E; Gemici B; Dilmac S; Ozkan A; Agar A; Aslan M
Neurochem Int; 2014 Dec; 79():1-11. PubMed ID: 25263280
[TBL] [Abstract][Full Text] [Related]
9. Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease.
Noelker C; Schwake M; Balzer-Geldsetzer M; Bacher M; Popp J; Schlegel J; Eggert K; Oertel WH; Klockgether T; Dodel RC
Neurosci Lett; 2012 Jan; 507(1):10-5. PubMed ID: 22155091
[TBL] [Abstract][Full Text] [Related]
10. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats.
Ferrigno A; Vairetti M; Ambrosi G; Rizzo V; Richelmi P; Blandini F; Fuzzati-Armentero MT
Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):695-703. PubMed ID: 25904005
[TBL] [Abstract][Full Text] [Related]
11. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
Kopalli SR; Noh SJ; Koppula S; Suh YH
Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
[TBL] [Abstract][Full Text] [Related]
12. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
[TBL] [Abstract][Full Text] [Related]
13. 6-hydroxydopamine affects multiple pathways to induce cytotoxicity in differentiated LUHMES dopaminergic neurons.
Ali N; Sane MS; Tang H; Compher J; McLaughlin Q; Jones CD; Maffi SK
Neurochem Int; 2023 Nov; 170():105608. PubMed ID: 37678429
[TBL] [Abstract][Full Text] [Related]
14. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ
Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517
[TBL] [Abstract][Full Text] [Related]
16. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
Roghani M; Niknam A; Jalali-Nadoushan MR; Kiasalari Z; Khalili M; Baluchnejadmojarad T
Brain Res Bull; 2010 Jul; 82(5-6):279-83. PubMed ID: 20558255
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
18. Detoxification of 6-hydroxydopamine-induced Parkinsonian neurodegeneration by G-CYPMPO, a novel radical trapper.
Kitamura Y; Kamibayashi M; Inden M; Yanagida T; Shibaike T; Takata K; Yasui H; Yamashita M; Taniguchi T
Neurochem Int; 2011 May; 58(6):721-7. PubMed ID: 21333707
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the motor cortical and striatal glutamatergic system and D-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson's disease.
El Arfani A; Albertini G; Bentea E; Demuyser T; Van Eeckhaut A; Smolders I; Massie A
Neurochem Int; 2015 Sep; 88():88-96. PubMed ID: 26172319
[TBL] [Abstract][Full Text] [Related]
20. A tetracycline-regulated adenovirus encoding dominant-negative caspase-9 is regulated in rat brain and protects against neurotoxin-induced cell death in vitro, but not in vivo.
Ebert AD; Chen F; He X; Cryns VL; Bohn MC
Exp Neurol; 2005 Feb; 191 Suppl 1():S80-94. PubMed ID: 15629764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
